Camillo Ricordi - Publications

Corrigendum to Correction of diabetes mellitus by transplanting minimal mass of syngeneic islets into vascularized small intestinal segment American Journal of Transplantation. Volume 13, Issue 10, October 2013, Pages 2550-2557.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: June 11, 2026

Ironing Out Possible Micronutrient Deficiencies Associated with Incretin Receptor Agonist-Based Therapies: Proposed Practical Strategies to Prevent and Manage Iron Deficiency.

Journal: Nutrients

Published: May 16, 2026

Optimizing 3D-printed Scaffold Geometry Decreases Foreign Body Response and Enhances Allogeneic Islet Transplant Outcomes.

Journal: bioRxiv : the preprint server for biology

Published: February 12, 2026

Towards integration of healthspan strategies into the Italian National Health Service.

Journal: Aging

Published: December 16, 2025

Choosing the right calcium channel blocker for patients with hypertension and proteinuric chronic kidney disease.

Journal: Current medical research and opinion

Published: August 06, 2025

Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes.

Journal: The New England journal of medicine

Published: June 22, 2025

Combined Use of Vitamin D and DPP-4 Inhibitors as a Potential Adjuvant Treatment Strategy to Enhance the Efficacy of Novel Beta-Cell Replacement Therapies for Type 1 Diabetes.

Journal: Medical sciences (Basel, Switzerland)

Published: May 10, 2025

Advances in Cell Replacement Therapies for Diabetes.

Journal: Diabetes

Published: January 14, 2025

25(OH) Vitamin D Levels and Severity of Type 1 Diabetes in Youth and Adults With Recent-Onset Disease.

Journal: Journal of the Endocrine Society

Published: January 10, 2025

Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults.

Journal: Journal of clinical medicine

Published: November 30, 2024

Pancreatic β-cell regeneration in situ by the ALK3 agonist THR-123.

Journal: Nature communications

Published: November 23, 2024

Demise of cadaveric islet transplantation in the USA: Quo Vadis, 1 year after BLA approval and 24 years after the Edmonton breakthrough?

Journal: Frontiers in transplantation

Published: September 05, 2024